References
- Ciobanu N, Welte K, Kruger G, Venuta S, Gold J, Feldman P, Wang C, Koziner B, Moore M AS, Safai B, Mertclrnann R. Defective T cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correlation by interleukin 2. J Clin Immun 1983; 3: 332–340
- Hofmann B, Jakobsen K D, Ødum N, Dickmeiss E, Plaz P, Ryder L P, Pedersen C, Mathiesen L, Bygbjerg I, Faber V, Svejgaard A. HIV-induced immunodeficiency: relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly responses via CD2/ phytohemagglutinin pathway. J Immun 1989; 142: 1874–1880
- Hofmann B, Nishanian P, Nguyen T, Liu M, Fahay J L. Restoration of T cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS 1993; 7: L659–664
- Lane H C, Depper J M, Greene W C, Whalen G, Waldmann T A, Fauci A S. Quantitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985; 313: 79–84
- Prince H E, Kermani-arab V, Fahey J L. Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathysyndromes. J Immun 1984; 133: 1313–1317
- Clerici M, Stocks N I, Zajac R A, Boswell R N, Bernstein D C, Mann D L, Shearer G M, Berzofsky J A. Interleukin-2 production used to detect antigenic peptide recognition by T helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 1989; 339: 383
- Maggi E, Mazzetti M, Ravina A, Annunziato F, De Carli M, Piccinni M P, Manetti R, Carbonari M, Pesce A M, Del Prete G, Romagnani S. Ability of HIV to promote a Thl to ThO shift and to replicate preferentially in Th2 and ThO cells. Science 1994; 265: 244–248
- Meroni L, Trabattoni D, Balotta C, Riva C, Gori A, Meroni M, Villa M L, Clerici M, Galli M. Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS 1996; 10: L23–30
- Clerici M, Shearer G M. A TH1 → TH2 switch is a critical step in the aetiology of HIV infection. Immun Today 1993; 14: 107–111
- Hofmann B, Nishanian P, Nguyen T, Insixiengmay P, Fahay J L. HIV proteins induce the inhibitory cAMP/protein kinase A pathway in normal T lymphocytes. Proc Natl Acad Sci USA 1993; 90: 6676–6680
- Nielsen S D, Nielsen J O, Hansen J-ES. In vitro separation and expansion of CD4 lymphocytes from HIV-infected individuals without activation of HIV-infection. J Immun Meth 1996, (in press)
- Miedema F, Petit A JC, Terpstra F G, Schattenkerk J KMF, de Wolf F, Al B JM, Roos M, Lange J MA, Danner S A, Goudsmit J, Schellekens PThA. Immunologicalabnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men: HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 1988; 82: 1908–1914
- Novak T J, Rothenberg E V. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc Natl Acad Sci USA 1990; 87: 9353–9357
- Krause D S, Deutsch C. Cyclic AMP inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. J Immun 1991; 146: 2285–2294
- Aune T M, McGrath K M, Sarr T, Bombara M P, Kelley K A. Expression of 5HTla receptors on activated human T cells. J Immun 1993; 151: 1175–1183
- Peroutka S J. 5-Hydroxytryptamine receptors. Scand J Neurochem 1993; 60: 408–416